Kathy L. Moser

Kathy L. Moser

Auto-generated profile, based on publicly available information

Kathy L. Moser

Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK 73104, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2009 in Genes & Immunity
Verified
Journal Article
Open access
PDF file
KMK L Moser
K L Moser
JKJ A Kelly
J A Kelly
CLC J Lessard
C J Lessard
JHJ B Harley
J B Harley
Genetic variation was first shown to be important in systemic lupus erythematosus (SLE or lupus) in the 1970s with associations in the human leukocyte antigen region. Almost four decades later, and with the help of increasingly powerful genetic approaches, more than 25 genes are now known to contribute to the mechanisms that predispose individuals to lupus. Over half of these loci have been discovered in the past 2 years, underscoring the extraordinary success of genome-wide association approaches in SLE. Well-established risk factors include alleles in the major histocompatibility complex region (multiple genes), IRF5, ITGAM, STAT4, BLK, BANK1, PDCD1, PTPN22, TNFSF4, TNFAIP3, SPP1, some of the Fcγ receptors, and deficiencies in several complement components, including C1q, C4 and C2. As reviewed here, many susceptibility genes fall into key pathways that are consistent with previous studies implicating immune complexes, host immune signal transduction and interferon pathways in the pathogenesis of SLE. Other loci have no known function or apparent immunological role and have the potential to reveal novel disease mechanisms. Certainly, as our understanding of the genetic etiology of SLE continues to mature, important new opportunities will emerge for developing more effective diagnostic and clinical management tools for this complex autoimmune disease.

30 April 2009 in Genes & Immunity
Verified
Journal Article
Open access
PDF file
EEE S Emamian
E S Emamian
JLJ M Leon
J M Leon
CLC J Lessard
C J Lessard
MGM Grandits
M Grandits
EBE C Baechler
E C Baechler
KMK L Moser
K L Moser
Sjögren's syndrome (SS) is a common chronic autoimmune disease characterized by lymphocytic infiltration of exocrine glands. The affected cases commonly present with oral and ocular dryness, which is thought to be the result of inflammatory cell-mediated gland dysfunction. To identify important molecular pathways involved in SS, we used high-density microarrays to define global gene expression profiles in the peripheral blood. We first analyzed 21 SS cases and 23 controls, and identified a prominent pattern of overexpressed genes that are inducible by interferons (IFNs). These results were confirmed by evaluation of a second independent data set of 17 SS cases and 22 controls. Additional inflammatory and immune-related pathways with altered expression patterns in SS cases included B- and T-cell receptor, insulin-like growth factor-1, granulocyte macrophage-colony stimulating factor, peroxisome proliferator-activated receptor-α/retinoid X receptor-α and PI3/AKT signaling. Exploration of these data for relationships to clinical features of disease showed that expression levels for most interferon-inducible genes were positively correlated with titers of anti-Ro/SSA (P<0.001) and anti-La/SSB (P<0.001) autoantibodies. Diagnostic and therapeutic approaches targeting interferon-signaling pathway may prove most effective in the subset of SS cases that produce anti-Ro/SSA and anti-La/SSB autoantibodies. Our results strongly support innate and adaptive immune processes in the pathogenesis of SS, and provide numerous candidate disease markers for further study.

1 April 2012 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CLChristopher J. Lessard
Christopher J. Lessard
IAIndra Adrianto
Indra Adrianto
JIJohn A. Ice
John A. Ice
GWGraham B. Wiley
Graham B. Wiley
JKJennifer A. Kelly
Jennifer A. Kelly
KMKathy L. Moser
Kathy L. Moser

1 January 2011 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
CLChristopher J. Lessard
Christopher J. Lessard
IAIndra Adrianto
Indra Adrianto
JKJennifer A. Kelly
Jennifer A. Kelly
KKKenneth M. Kaufman
Kenneth M. Kaufman
KGKiely M. Grundahl
Kiely M. Grundahl
KMKathy L. Moser
Kathy L. Moser

1 August 2012 in Journal of Autoimmunity
Verified
Journal Article
Closed access
JIJohn A. Ice
John A. Ice
HLHe Li
He Li
IAIndra Adrianto
Indra Adrianto
PLPaul Chee Lin
Paul Chee Lin
JKJennifer A. Kelly
Jennifer A. Kelly
KMKathy L. Moser
Kathy L. Moser

1 November 2008 in Rheumatic Disease Clinics of North America
Verified
Journal Article
Closed access
BCBeth L. Cobb
Beth L. Cobb
CLChristopher J. Lessard
Christopher J. Lessard
JHJohn B. Harley
John B. Harley
KMKathy L. Moser
Kathy L. Moser